However, Wnt5a has also been reported to play an opposing tumor-suppressive role by abrogating the YAP/TAZ pathway, as evidenced by its negative feedback in the ROR2-YAP/TAZ pathway in a prostate cancer model [39]. The gene discussed is ROR2; the disease is prostate cancer.